Stage Dependent Aberrant Regulation of Cytokine-STAT Signaling in Murine Systemic Lupus Erythematosus
Open Access
- 25 August 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (8) , e6756
- https://doi.org/10.1371/journal.pone.0006756
Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves multiple interacting cell types driven by numerous cytokines and autoimmune epitopes. Although the initiating events leading to SLE pathology are not understood, there is a growing realization that dysregulated cytokine action on immune cells plays an important role in promoting the inflammatory autoimmune state. We applied phospho-specific flow cytometry to characterize the extent to which regulation of cytokine signal transduction through the STAT family of transcription factors is disturbed during the progression of SLE. Using a panel of 10 cytokines thought to have causal roles in the disease, we measured signaling responses at the single-cell level in five immune cell types from the MRLlpr murine model. This generated a highly multiplexed view of how cytokine stimuli are processed by intracellular signaling networks in adaptive and innate immune cells during different stages of SLE pathogenesis. We report that robust changes in cytokine signal transduction occur during the progression of SLE in multiple immune cell subtypes including increased T cell responsiveness to IL-10 and ablation of Stat1 responses to IFNα, IFNγ, IL-6, and IL-21, Stat3 responses to IL-6, Stat5 responses to IL-15, and Stat6 responses to IL-4. We found increased intracellular expression of Suppressor of Cytokine Signaling 1 protein correlated with negative regulation of Stat1 responses to inflammatory cytokines. The results provide evidence of negative feedback regulation opposing inflammatory cytokines that have self-sustaining activities and suggest a cytokine-driven oscillator circuit may drive the periodic disease activity observed in many SLE patients.Keywords
This publication has 51 references indexed in Scilit:
- Robust, Tunable Biological Oscillations from Interlinked Positive and Negative Feedback LoopsScience, 2008
- How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targetsImmunological Reviews, 2008
- Analysis of Significance Patterns Identifies Ubiquitous and Disease‐Specific Gene‐Expression Signatures in Patient Peripheral Blood LeukocytesAnnals of the New York Academy of Sciences, 2005
- Cell Cycle: Bistability Is Needed for Robust CyclingCurrent Biology, 2005
- The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signallingBiochemical Journal, 2004
- Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB MiceThe Journal of Experimental Medicine, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 2003
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α TreatmentActa Oncologica, 1991
- Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice.The Journal of Experimental Medicine, 1990